Magnéitesch Perle-baséiert Nukleinsäure Extraktioun Technologie: Féierung vun der Effizienzrevolutioun an der biopharmazeutescher Industrie

In the current era of surging demands for precision medicine and large-scale disease screening, a key technology is quietly driving the efficiency revolution in the biopharmaceutical industry – magnetesch Perle-baséiert Nukleinsäure Extraktioun. With its significant advantages of high efficiency, Automatisatioun, and high purity, this technology has rapidly become an indispensable core tool in molecular diagnostics, Gen Sequenzéierung, and new drug development fields.

Mat eisem Serum / Plasma Virus Nukleinsäure Extraktiounsreagenz, HBV national Standard Gradient Verdünnungsmëttel goufen op der automatescher Nukleinsäure Extraktioun a Reinigungsinstrument LJbio32H extrahéiert. Déi extrahéiert Produkter vun all Konzentratiounsgradient-Diluent goufen duerch HBV-qPCR festgestallt, mat engem Korrelatiounskoeffizient R>0.99. Déi spezifesch Donnéeën sinn wéi follegt:

Resultat Analyse：D'Genauegkeet vum Reagens ass ganz héich, an d'Sensibilitéit ass nach ëmmer gutt wann Dir niddereg Konzentratioun Echantillon extrahéiert.

Compared with the traditional centrifugal column method, magnetic bead-based extraction achieves rapid separation and purification through the specific binding of nucleic acids to surface-modified magnetic particles under the action of an external magnetic field. This principle enables breakthroughs in throughput, Vitesse, and consistency. An de leschte Joren, this technology has excelled in scenarios such as large-scale screening of infectious diseases (such as COVID-19 nucleic acid testing), tumor liquid biopsy (microscopic ctDNA capture), and genetic disease analysis, effectively supporting high-throughput, standardized modern testing requirements.

Nucleic acids were extracted from trace amounts of human Hela cells as samples, 5 Zellen, 10 Zellen, 20 Zellen, 500 cells were extracted, and the nucleic acids obtained were analyzed using Agilent 4200 Nucleic acid fragment distribution, and the results obtained are shown below: 

1. The Electropherogram of Agilent 4200 High Sensitivity RNA ScreenTape Assay

D1: 50 Hela cellsG1: 20 Hela cellsB2: 10 Hela cellsE2: 5 Hela cells

2. Peak diagram of the 50/20/10/5 Hela cells extracted

• Peak diagram of the 5 Hela cells extracted

• . Qubit’s test results

Nee.	Prouf Aufnahme	Rendement（ng/μL)
1	50 Hela cells	0.242
2	20 Hela cells	0.136
3	10 Hela cells	0.112
4	5 Hela cells	0.096

Resultat Analyse： By Agilent 4200 electrophoresis results can be seen: 5– 50 traces of human Hela cell samples, can be obtained by the nucleic acid fragments, The extraction products were 18s RNA, 28sRNA, and DNA over 800bp.

The wave of industry innovation continues to surge. Domestic leading enterprises have launched fully automated solutions integrating magnetic bead extraction, erreechen “sample input and result output” in closed tubes, reducing extraction time to minutes and significantly enhancing emergency testing capabilities. Gläichzäiteg, breakthroughs in domestic high-end magnetic bead raw materials, such as those from companies like Shanghai Lingjun Biotechnology, have broken the import monopoly, reducing the cost of a single sample by over 30%, significantly enhancing the autonomy of the industrial chain. Capital markets have shown great favor for this sector, with many related enterprises completing large-scale financing recently, driving technological iteration into a fast lane.

Op d'Zukunft kucken, with the explosion of personalized medical care and immediate testing (POCT) demands, magnetic bead-based technology is evolving towards higher sensitivity, better anti-interference performance, and green biodegradability. Its combination with microfluidics and artificial intelligence is expected to give rise to a new generation of intelligent extraction platforms, continuously providing key infrastructure for the innovation and development of the biopharmaceutical industry.

Fournisseur

Shanghai Lingjun Biotechnology Co., Ltd., Ltd.gouf etabléiert an 2016 deen e professionnelle Hiersteller vu biomagnetesche Materialien an Nukleinsäure Extraktiounsreagenz ass.

Mir hu räich Erfahrung an Nukleinsäure Extraktioun an Offäll, Protein Reinigung, Zell Trennung, Chemilumineszenz, an aner technesch Beräicher.

Eis Produkter gi wäit a ville Beräicher benotzt, wéi medizinesch Tester, genetesch Tester, Universitéit Fuerschung, genetesch Zucht, an esou weider. Mir bidden net nëmmen Produkter, awer och kënnen OEM ënnerhuelen, ODM, an aner Besoinen. Wann Dir e verbonne Besoin hutt, weg fillen gratis eis ze kontaktéieren .